home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
   
 

news archive genetic news - November 23, 2004

 
  November 23, 2004
your information resource in human molecular genetics
 
     
- Corautus Genetics Announces Publication of Gene Therapy Approach to Heart Disease in Circulation
Corautus' technology is currently being tested in a Phase IIb trial known as GENASIS ("Genetic Angiogenic Stimulation Investigational Study")
- New Protein “Stop Sign” Alters Blood Vessel Growth
Semaphorin 3E and Plexin-D1 Control Vascular Pattern Independently of Neuropilins
- A Molecular Light Switch Silences Neurons
A technical report describes a new technique for rapid, reversible and precise silencing of neural activity that overcomes limitations of past techniques.
- How People Learn From Mistakes
A rare opportunity not only to record from single human brain cells, but also to study the effects of their loss suggests that a certain brain area may be important for our ability to form effective strategies.
- Busting Up Gallstones
A compound that alters the composition of the digestive fluid bile might prevent gallstone formation.
- West Nile Virus: Crossing Into The Brain
Researchers have discovered how West Nile virus enters the brain.
- Cancer Spreads
An Insight in the 18 Nov 2004 issue of Nature captures the excitement in the rapidly advancing field of cancer research.
- New Evidence For Cancer Stem Cells
An original study identifies brain tumour initiating cells and suggests them as new targets for more effective cancer therapies.
- Non-Coding RNA Helps To Regulate Insulin
New study provides hope for diabetes drug development by showing the power of a class of non-coding RNAs thought to regulate gene expression.
- Cutting Cholesterol With RNAi
Scientists report a simple and ground-breaking new way to use RNAi to cut cholesterol levels in mice.

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.